HF Treatment According to Diagnosis
| HF treatment* | Total | ||||
|---|---|---|---|---|---|
| Diagnosis groups | None | ARB and/or ACEI | β-blocker only | β-blocker and ACEI and/or ARB | |
| COPD, n (%) | 55 581 (61.9) | 24 636 (27.4) | 3918 (4.4) | 5726 (6.4) | 89 861 (100) |
| HF, n (%) | 5709 (23.6) | 6576 (27.1) | 1950 (8.1) | 10 002 (41.3) | 24 237 (100) |
| COPD and HF, n (%) | 3019 (27.8) | 4864 (44.8) | 554 (5.1) | 2416 (22.3) | 10 853 (100) |
*Considering ARB, ACEI and β-blocker prescriptions only.
ACEI, ACE inhibitor; ARB, angiotensin-2 receptor blockers; COPD, chronic obstructive pulmonary disease; HF, heart failure.